Overexpression of bcl-2 in transient abnormal myelopoiesis associated with Down syndrome

Annals of Hematology

Volumn 79, Issue 6, 2000, Pages 319-321

  Yoshioka, K ^a   Yamamoto, S ^a   Moriguchi, N ^a   Miyata, H ^a   Tsukiyama, K ^a   Isokawa, S ^a   Horiuchi, F ^a   Takemura, T ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; bcl 2; Down syndrome; Transient abnormal myelopoiesis

Indexed keywords

FAS ANTIGEN; PROTEIN BCL 2; PROTEIN P53;

ARTICLE; BLAST CELL; BLOOD CELL; BLOOD DISEASE; CASE REPORT; CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DOWN SYNDROME; FLOW CYTOMETRY; GEL ELECTROPHORESIS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INFANT; MALE; MONONUCLEAR CELL; MYELOPOIESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION;

DOWN SYNDROME; GENES, BCL-2; HUMANS; INFANT, NEWBORN; LEUKOPOIESIS; MALE;

EID: 0034041897     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002779900138     Document Type: Article

References (15)

1. Bikoue A, George F, Poncelet P, Mutin M, Janossy G, Sampol J (1996) Quantitative analysis of leukocyte membrane antigen expression: normal adult values. Cytometry 26: 137-147
2. Duke R, Cohen J (1986) IL-2 addiction: withdrawal of growth factor activates a suicide program in dependent T cells. Lymphokine Res 5: 289-299
3. Hale A, Smith C, Sutherland L, Stoneman V, Longthorne V, Culhane A, Williams G (1996) Apoptosis: molecular regulation of cell death. Eur J Biochem 236: 1-26
4. Hockenbery D, Nunez G, Milliman C, Schreiber R, Korsmeyer S (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334-336
5. Kempski H, Craze J, Chessells J, Reeves B (1998) Cryptic deletions and inversions of chromosome 21 in a phenotypically normal infant with transient abnormal myelopoiesis: a molecular cytogenetic study. Br J Haematol 103: 473-479
6. Korsmeyer S (1992) Bcl-2: a repressor of lymphocyte death. Immunol Today 13: 285-288
7. Kurahashi H, Hara J, Yumura-Yagi K, Murayama N, Inoue M, Ishihara S, Tawa A, Okada S, Kawa-Ha K (1991) Monoclonal nature of transient abnormal myelopoiesis in Down's syndrome. Blood 77: 1161-1163
8. Kurahashi H, Hara J, Yumura-Yagi K, Tawa. A, Kawa-Ha K (1992) Transient abnormal myelopoiesis in Down's syndrome. Leuk Lymphoma 8: 465-475
9. Litz C, Davies S, Brunning R, Kueck B, Parkin J, Gajl Peczalska K, Arthur D (1995) Acute leukemia and the transient myeloproliferative disorder associated with Down syndrome: morphologic, immunophenotypic and cytogenetic manifestations. Leukemia 9: 1432-1439
10. Miyazato H, Takemura T, Hino S, Yagi K, Fukushima K, Matsuo O, Yoshioka K (1998) Glucocorticoid-induced apoptosis of rat mesangial cells in culture. Clin Exp Nephrol 2: 12-17
11. Nagao T, Lampkin B, Hug G (1970) A neonate with Down's syndrome and transient abnormal myelopoiesis. Blood 36: 443-447
12. Nagata S (1997) Apoptosis by death factor. Cell 88: 355-365
13. Pezzella F, Tse A, Cordell J, Pulford K, Gatter K, Mason D (1990) Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Am J Pathol 137: 225-232
14. Ridgway D, Benda G, Magenis E, Allen L, Segal G, Braziel R, Neerhout R (1990) Transient myeloproliferative disorder of the Down type in the normal newborn. Am J Dis Child 144: 1117-1119
15. Tsujimoto Y, Croce C (1986) Analysis of the structure, transcripts and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci U S A 83: 5214-5218